BriaCell Therapeutics Corp. (BCTXW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Feb 12Feb 18Feb 23Feb 26Mar 10Mar 13Mar 18Mar 23

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.1x

Market Cap

$1695.52

MomentumView details →

1D Return

−0.00%

YTD Return

−98.30%

RSI (14)

26.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.1x

Market Cap

$1695.52

RSI (14)

26.8

MomentumView details →

1D Return

−0.00%

YTD Return

−98.30%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−109.39%

ROA (TTM)

−100.67%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

−68.39%

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

−44.42%

EarningsView details →

EPS (Actual)

−$315.47

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.10x

Quick Ratio

10.10x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−45.80M

Op. CF (TTM)

−37.04M

Latest newsMore news →

BriaCell Therapeutics Corp. completed a best-efforts follow-on offering of 1,449,300 common shares at $3.25 per share for gross proceeds of $4.71 million, with ThinkEquity LLC as placement agent.94d ago

Similar companies

Lipella Pharmaceuticals Inc.LIPO CERo Therapeutics Holdings, Inc.CEROW Dermata Therapeutics, Inc.DRMAW Abpro Holdings IncABPWW Moolec Science S.A.MLECW Aditxt, Inc.ADTX Find similar companies →

Latest newsMore news →

BriaCell Therapeutics Corp. completed a best-efforts follow-on offering of 1,449,300 common shares at $3.25 per share for gross proceeds of $4.71 million, with ThinkEquity LLC as placement agent.94d ago